Paul J. Schechter

Pharmacokinetics and Tolerability of Intravenous Trecovirsen (GEM®91), an Antisense Phosphorothioate Oligonucleotide, in HIV‐Positive Subjects

R. Tubiana, C. Katlama, P. Schechter, 1999, Journal of clinical pharmacology.

Phase I-II clinical trial with alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.

L. Marton, P. Schechter, Y. Horn, 1987, European journal of cancer & clinical oncology.